NurExone Reports Positive Results for Intranasal ExoPTEN in Spinal Cord Regeneration and Reinnervation in Rats

NurExone Biologic Inc. has reported positive imaging results from an internal preclinical study of its investigational drug ExoPTEN, which demonstrated successful nerve regeneration following traumatic transection of the spinal cord in rats. The company's ExoPTEN drug caused 75% of rats to regain hind limb reflex, some motor function, and sensory control. Subsequently, advanced Diffusion Tensor ..